Dokumente
Suchschritt : FT=glucosamine AND FT=osteoarthritis
» Fenster schließen »
2/93 von 416    DIMDI: MEDLINE (ME60) © NLM
ND: ME16164945
PMID: 16164945
CED: 20050916
DCO: 20051122
Autoren: Hanypsiak BT; Shaffer BS
Titel: Nonoperative treatment of unicompartmental arthritis of the knee.
Quelle: The Orthopedic clinics of North America; VOL: 36 (4); p. 401-11 /200510/
PM: Print
SU: AIM
IM
Sprache: English
CY: United States
JID: 0254463
ISSN: 0030-5898
CO: OCLNAQ
Institution: Orthopaedic Associates of Long Island, 6 Technology Drive, Suite 100, East Setauket, New York 11733, USA. bhanypsiak@optonline.net
DT: Journal Article; Review
RN: 103
Schlagwörter
CT: ADJUVANTS, IMMUNOLOGIC/administration & dosage; ADJUVANTS, IMMUNOLOGIC/therapeutic use; ADMINISTRATION, TOPICAL; ANALGESICS, NON-NARCOTIC/administration & dosage; ANALGESICS, NON-NARCOTIC/therapeutic use; ANTI-INFLAMMATORY AGENTS/administration & dosage; ANTI-INFLAMMATORY AGENTS/therapeutic use; ARTHROSCOPY; CHONDROITIN/therapeutic use; CORTISONE/administration & dosage; CORTISONE/therapeutic use; DIETARY SUPPLEMENTS; GLUCOSAMINE/therapeutic use; HUMANS; HYALURONIC ACID/administration & dosage; HYALURONIC ACID/therapeutic use; INJECTIONS, INTRA-ARTICULAR; LIFE STYLE; ORTHOTIC DEVICES; OSTEOARTHRITIS, KNEE/*therapy
CTG: ADJUVANZIEN, IMMUNOLOGISCHE/Verabreichung & Dosierung; ADJUVANZIEN, IMMUNOLOGISCHE/therapeutische Anwendung; APPLIKATION, LOKALE; ANALGETIKA, NICHTNARKOTISCHE/Verabreichung & Dosierung; ANALGETIKA, NICHTNARKOTISCHE/therapeutische Anwendung; ANTIPHLOGISTIKA/Verabreichung & Dosierung; ANTIPHLOGISTIKA/therapeutische Anwendung; ARTHROSKOPIE; CHONDROITIN/therapeutische Anwendung; CORTISON/Verabreichung & Dosierung; CORTISON/therapeutische Anwendung; NAHRUNGSERGÄNZUNGSMITTEL; GLUCOSAMIN/therapeutische Anwendung; MENSCH; HYALURONSÄURE/Verabreichung & Dosierung; HYALURONSÄURE/therapeutische Anwendung; INJEKTIONEN, INTRAARTIKULÄRE; LEBENSSTIL; ORTHETISCHE VORRICHTUNGEN; OSTEOARTHROSE, KNIE/*Therapie
TE: Adjuvants, Immunologic; Analgesics, Non-Narcotic; Anti-Inflammatory Agents; Glucosamine/3416-24-8; Cortisone/53-06-5; Hyaluronic Acid/9004-61-9; Chondroitin/9007-27-6
CR: 3416-24-8; 53-06-5; 9004-61-9; 9007-27-6
AB: Treatment of the knee with unicompartmental osteoarthritis remains a challenging clinical problem. Despite pharmacologic advances and surgical innovations, the ideal strategy for the patient who has single-compartment degenerative disease can be complicated. The understanding and management of this problem are further confounded by the fact that so much of the data are unreliable. Given these constraints, this article outlines the current alternatives available in nonoperatively managing the symptomatic unicompartmental arthritic knee.
» Volltext »

» Fenster schließen »